News
Mabwell’s subsidiary T-mab enters into an agreement with Qilu Pharma for Albipagrastim alfa for injection: Shanghai Monday, June 30, 2025, 15:00 Hrs [IST] Mabwell, an innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback